Fundraising Fox

Telegraph Hill Partners β€” Full Portfolio

29 tracked investments Β· listed companies and verified rows first

Cell Microsystemscellmicrosystems.cominNov 2021βœ“ verified

Cell Microsystems develops automated instruments for cellular and molecular workflows used in life science research, including oncology, stem cell biology, and regenerative medicine.

BiotechDeep TechHardwareMedical DevicesDurham, US

Scott McGinnis(President)Nancy Allbritton(Director)Yuli Wang(Director)Matthew Megaro(Director)Gary Pace(Executive Officer, Director)Christopher Sims(Executive Officer, Director)

Board seatDeval LashkariRob CaponeΒ· per SEC Form D

Co-investorsIDEA NC

ETHERFAXetherfax.netinπ•βœ“ verified

etherFAX provides cloud-based secure document delivery and fax transmission for businesses handling sensitive information.

AI & Machine LearningCloud ComputingCybersecurityEnterprise SoftwareHealthtechSaaS

Paul Banco(Co-Founder and EVP of Federal Programs)Rob Cichielo(Co-Founder and Chief Technology Officer)Jay Volk(Chief Executive Officer)Emil Sturniolo(Chief Security Officer)Allison Kirsch(Chief Marketing Officer)

Magstim Groupmagstim.cominπ•βœ“ verified

Magstim develops neurotechnology and neurostimulation devices for healthcare providers and researchers, focusing on neuromodulation and neurophysiology applications.

Deep TechHardwareHealthtechMedical DevicesMental HealthSan Francisco, US

BoardThomas A. Raffin(Executive Officer, Director)J. Matthew Mackowski(Executive Officer, Director)

N6Tecn6tec.cominπ•βœ“ verified

n6 is a genomics technology company that develops methods and tools for molecular R&D and genomics research.

BiotechDeep TechHardwareMedical Devices

Akoyabioakoyabio.comin𝕏Jul 2017acquired by Quanterix

BiotechHealthtechMedical DevicesBillerica, US

Brian McKelligon(Executive Officer)Garry Nolan(Director)Matthew Winkler(Director)

BoardRob Hart(Executive Officer)inThomas Raffin(Director)in

Board seatRobert SheplerΒ· per SEC Form D

Co-investorsaMoon

Aquaro HistologyMay 2017SEC filinghigh confidence

BiotechAnn Arbor, US

Alberto Elli(Executive Officer, Director)Jack Ball(Executive Officer, Director)

BoardThomas Raffin(Director)in

Board seatDeval LashkariRob HartΒ· per SEC Form D Β· $9.8M raise Β· filed Jun 2017

Argonaut Manufacturing ServicesMar 2016SEC filinghigh confidence

HealthtechCarlsbad, US

WAYNE WOODARD(Executive Officer, Director)

BoardALEXANDER HERZICK(Director)inRICK HANCOCK(Director)

Board seatDeval LashkariPaul GrossmanΒ· per SEC Form D Β· $10.3M raise Β· filed Apr 2016

Community BioNov 2021SEC filinghigh confidence

BiotechSan Diego, US

Robert Finzi(Director)David Wellis, Ph.D.(Executive Officer, Director)

BoardAlex Herzik(Director)

Board seatDeval LashkariPaul GrossmanΒ· per SEC Form D Β· $15M raise Β· filed Nov 2021

Emerging Therapy SolutionsDec 2022SEC filinghigh confidence

HealthtechBloomington, US

Steve Lefar(Director)David McLean(Executive Officer, Director)Ravi Nalliah(Director)Kevin Roche(Executive Officer, Director)

BoardJeanette Welsh(Director)inJ. Matthew Mackowski(Director)

Board seatRob CaponeGary CurtisΒ· per SEC Form D Β· filed Dec 2022

Invisalert Solutionsinvisalertsolutions.cominMar 2019

Invisalert Solutions provides a patient safety platform using machine learning and AI to monitor and prevent adverse events such as falls, infections, and elopement across acute care, emergency departments, behavioral health, and long-term care facilities.

AI & Machine LearningEnterprise SoftwareHealthtechWest Chester, US

Pete Nagy(Executive Officer, Director)Mark Gold(Director)

BoardRegina Widdow(Director)

Board seatRob HartGary CurtisTom RaffinΒ· per SEC Form D

Mosaicbiomosaicbio.cominJan 2023

Mosaic Biosciences is a biologics discovery company that advances biologic drug candidates from discovery through IND-enabling studies and clinical development, working with partners across multiple therapeutic modalities.

BiotechDeep TechBoulder, US

Marty (Martin) Stanton(Founder & former CEO)Eric Furfine(Chief Scientific Officer)Alexei Kazantsev(Vice President Protein Design and Engineering)Tracey Mullen(Chief Strategy Officer)Scott Glaser(SVP, Biologics Discovery)Jean-Pierre Wery(Chief Executive Officer)

Board seatJeanette WelshRob CaponeΒ· per SEC Form D

Nimble Therapeuticsnimbletherapeutics.comin𝕏Apr 2019

A biopharmaceutical company that discovers and develops medicines, building on immunology research to explore additional disease areas.

BiotechHealthtechMadison, US

Jigar Patel(Executive Officer, Director)in

Board seatDeval LashkariRob HartΒ· per SEC Form D

Panome Biopanomebio.cominFeb 2023

Panome Bio provides metabolomics, proteomics, and multi-omics integration workflows along with a computational platform that analyzes and integrates diverse biological data types.

AI & Machine LearningBiotechDeep TechHealthtechSaint Louis, US

Edward Weinstein(Executive Officer, Director)inTom Cohen(Executive Officer)in

BoardDavid Smoller(Director)inAlexander Herzick(Director)in

Board seatDeval LashkariRob CaponeΒ· per SEC Form D

Co-investorsBioGenerator VenturesCultivation Capital

Precision NanoSystemsSep 2015SEC filingmedium confidence

BiotechVancouver

Andrew Booth(Director)Andrew J. Schwab(Director)inR. James Taylor(Executive Officer, Director)Joe Victor(Executive Officer, Director)Euan Ramsay(Executive Officer)Daniel Nixon(Director)

Board seatDeval LashkariΒ· per SEC Form D Β· $6M raise Β· filed Nov 2019

Co-investorsRising Tide5AM Ventures

Rarecyterarecyte.comJul 2017SEC filingmedium confidence

Seattle, US

Ronald Seubert(Executive Officer, Director, Promoter)Evan Castiglia(Executive Officer)Joseph Victor(Executive Officer, Director)Frank Witney(Director)Eric Kaldjian(Executive Officer)

Board seatRobert SheplerΒ· per SEC Form D Β· $16.3M raise Β· filed Aug 2017

Co-investors5AM VenturesArboretum VenturesF-Prime CapitalSofinnova Ventures

Argonautmsargonautms.comin𝕏

Argonaut Manufacturing Services provides contract manufacturing for life sciences and healthcare products, serving partners across the health and biotech industries with expertise in cGMP manufacturing, regulatory affairs, and operational scaling.

Advanced ManufacturingBiotechEnterprise SoftwareHealthtechSaaSBoston, US

Rick(CEO)

Carterra Biocarterra-bio.comin𝕏

Carterra designs and manufactures flexible microfluidic manufacturing systems for the life sciences and biotech research markets.

BiotechDeep TechMedical DevicesNew MaterialsSan Diego, US

Mr. Eckman(Founder)

Dynextechnologiesdynextechnologies.comin

DYNEX Technologies develops and manufactures automated ELISA and chemiluminescence microplate instruments for clinical and diagnostic laboratories.

HealthtechMedical Devices

Co-investorsAmpersand

Editcoeditco.bioin𝕏

EditCo manufactures arrayed CRISPR guide RNA libraries for functional genomics screening, using its proprietary XDel technology to achieve high-efficiency gene knockouts in human and mouse cell lines.

AI & Machine LearningBiotechDeep Tech

Emergingtherapiesemergingtherapies.comin

Emerging Therapy Solutions provides comprehensive management solutions for cell and gene therapies and transplants to payers, self-insured employers, and secondary payers.

HealthtechInsurTechMedical Devices

David J. McLean

Frontierfrontier.carein

Frontier is a telepsychiatry practice delivering remote psychiatric care to patients in rural Montana, Idaho, and Alaska without requiring referrals.

Digital HealthHealthtechMental HealthMontana, US

Montana psychiatrists

Htslabshtslabs.comin

Thomson manufactures laboratory consumables including filter vials, shake flasks, well plates, and chromatography columns for pharmaceutical, biotech, environmental, toxicology, and contract manufacturing sectors.

Advanced ManufacturingBiotechHealthtechMedical Devices

Melissa Ellis(Founder Emeritus)

Kytopenkytopen.cominApr 2026

Kytopen develops non-viral gene delivery technology called Flowfect that combines fluid flow with electric fields to deliver payloads such as mRNA, DNA, and CRISPR Cas9 RNP into cells for high-throughput transfection.

BiotechDeep TechHardwareCambridge, US

Cullen Buie(Director)inPaulo Garcia(Executive Officer, Director, Promoter)inMichael Chiu(Director, Executive Officer)in

BoardPaxton Major(Director)Ann DeWitt(Director)inPaul Wotton(Director)

Co-investorsBantam GroupHorizons VenturesMassVenturesSelvedge VentureTBD AngelsThe Engine Ventures+1 more

Nivagennivagen.comin

Nivagen provides drug product development services, guiding pharmaceutical companies through the full lifecycle from concept to commercialization, including traditional NDAs, 505(b)(2)s, and complex generics.

Advanced ManufacturingBiotechDigital HealthHealthtechMedical DevicesCalifornia, US

Dr. Nirav Patel

Promptlycheckinpromptlycheckin.comin𝕏

Promptly is a patient experience and engagement software suite for specialty medical practices, offering tools to automate practice operations and appointment scheduling.

Digital HealthEnterprise SoftwareHealthtechSaaS

RevMedicarevmedica.comMay 2023

RevMedica develops smart surgical stapling and soft tissue management systems for minimally invasive and robotic procedures, designed to provide real-time intraoperative data and improve clinical decision-making for surgeons.

AI & Machine LearningHealthtechMedical DevicesMiddletown, US

Thomas Wenchell(Chief Executive Officer and Co-Founder)inC. Robert Satti(Director)

Co-investorsConnecticut Innovations

Teknovateknova.comin

Teknova develops reagents and custom buffer solutions for AAV (adeno-associated virus) downstream processing in gene therapy workflows.

Advanced ManufacturingBiotechDeep Tech

Trakceltrakcel.comin𝕏

TrakCel develops technology solutions for clinical trial services and cell therapy supply chain management, including cold chain logistics and software platforms for advanced therapy deployment.

BiotechHealthtechLogistics & Supply ChainMedical DevicesSaaSWales, GB

Dr Matthew Lakelin(Head of Consultancy Services & Co-Founder)Ravi Nalliah(Chief Executive Officer)Dr Akshay Peer(Chief Product Officer)

Co-investorsCencora Ventures

Welconywelcony.com

Rows marked β€œSEC filing” are inferred from directors named on the company's SEC Form D β€” public regulatory data, not a portfolio list published by the firm.